Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 ...

The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.89 and a current ratio of 3.46. Edwards Lifesciences (NYSE ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, provides products and technologies for structural ...

Bank of New York Mellon Corp increased its position in shares of Edwards Lifesciences by 4.3% during the second quarter ...

Shortly after a win over the Denver Nuggets on Nov. 1, the Minnesota Timberwolves' Anthony Edwards was asked about people who thought he was taking too many three-pointers. After shooting 6.7 3 ...

MINNEAPOLIS (AP) — Anthony Edwards hit nine 3-pointers and scored 37 points to help the Minnesota Timberwolves beat the Portland Trail Blazers 127-102 on Friday night. The nine 3s on 15 attempts ...

If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting . Investors have until December 13, 2024 to ask the Court to be appointed to lead the case.